SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Morgan R., Gopalaswamy AK. Psychotropic drugs: Another survey of prescribing patterns. Br. J. Psychiatry 1984; 144: 298302.
  • 2
    Peralta V., Cuesta MJ, Caro F. Martinez-Larrea A. Neuroleptic dose and schizophrenic symptoms. Acta Psychiatr. Scand. 1994; 90: 354357.
  • 3
    Baldessarini RJ. Kando JC, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: Stable dosing with decreased length of stay. Am. J Psychiatry 1995; 152: 10381044.
  • 4
    Baldessarini RJ. Katz B., Cotton P.. Dissimilar dosing with high-potency and low-potency neuroleptics. Am. J. Psychiatry 1984; 141: 748752.
  • 5
    Johnson DAW, Wright NF. Drug prescribing for schizophrenic out-patients on depot injection. Br. J. Psychiatry 1990; 156: 827834.
  • 6
    Wilson WH, Ban TA. Guy W. Pharmacotherapy of chronic hospitalized schizophrenics: Prescription practices. Neuropsychohibiology 1985; 14: 7582.
  • 7
    Nichol MB, Stimmel GL. Lange SC. Factors predicting the use ot multiple psychotropic medication. J. Clin. Psychiatry 1995; 56: 6066.
  • 8
    Thompson C. The use of high-dose antipsychotic medication. Br. J. Psychiatry 1994; 164: 448458.
  • 9
    Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment ot psychoses. Arch. Gen. Psychiatry. 1988; 45: 7991.
  • 10
    Kane JM. Schizophrenia. N. Engl. J. Med. 1995; 334: 3441.
  • 11
    Chiu HFK, Shum PS, Lam CW. Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital. Int. J. Soc. Psychiatry 1991; 37: 187191.
  • 12
    Chiu H., Lee S., Leung CM, Wing YK. Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Aust. NZ. J. Psychiatry 1992; 26: 262264.
  • 13
    Ungvari GS, Pang AHT, Chiu HFK, Wong CK, Lum FCK. Psychotropic drug prescription m rehabilitation. Sec. Psychiatry Psychiatr. Epidemiol. 1996; 31: 288291.
  • 14
    Kass F., Charles E., Walsh T., Barsa J. Quality review of outpatient psychopharmacological practice with APA Task Force criteria. Am. J. Psychiatry 1983; 140: 221224.
  • 15
    Clark AF, Holden NL. The persistence of prescribing habits: A survey and tollow-up of prescribing to chronic hospital in-patients. Br. J. Psychiatry 1987; 150: 8891.
  • 16
    Warner JP. Slade R., Barnes TRE. Change in Neuroleptic prescribing practice. Psychiatr. Bull. 1995; 19: 237239.
  • 17
    Jin Z. Effect of an open-door policy combined with a structured activity programme on the residual symptoms of schizophrenic in-patients. Br. J. Psychiatry 1994: 165 (Suppl 24): 5257.
  • 18
    Viguera AC, Baldessarini RJ, Hegarty JD. van Kammen DP. Tohen M. Clinical risk following abrupt and gradual withdrawal ot maintenance neuroleptic treatment. Arch. Gen. Psychitiatry 1997; 54: 4955.
  • 19
    Barnes TRF. Commnet on the WHO Consensus Statement Br. J. Psychitiatry 1990 156. 413414.
  • 20
    WHO Consensus Statement Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. Br. J. Psychitiatry 1990 156: 412.
  • 21
    Douvle DB. Warren GC. Evanes M. Rowlands MP. Efficacy of meintenanse use of anticholouergic agents. Add Psychiatry Sand 1993 88: 318384.
  • 22
    Ayd FJ. Rational Pharmacoiherapy: Once-a-day drug dosage Nem. Syst. Syst. 1973: 34: 377378.
  • 23
    Bames TRE. Kane JM. Choosing between old and new anti choties. Cum. Opin. Psychiatry 1996 9: 4144.
  • 24
    Johus CA. Thompson JW. Adjunctive treatments in Schicophr Pharmacotherapic and clectrocomunlsive therapy. Schicophr. J. 1995 21 607619.